3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
2
Myeloid
1
CNS
1
Conditions
Neuroblastoma
16
Central Nervous System Neoplasms
13
Brain Neoplasms
9
Medulloblastoma
8
Rhabdoid Tumor
6
Astrocytoma
6
Sarcoma
5
Glioma
5
Oligodendroglioma
4
Lymphoma
4
Pinealoma
3
Osteosarcoma
3
Optic Nerve Glioma
3
Ependymoma
3
Testicular Neoplasms
2
Testicular Germ Cell Tumor
2
Teratoma
2
Spinal Cord Neoplasms
2
Rhabdomyosarcoma
2
Recurrence
2
Ovarian Neoplasms
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms
2
Kidney Neoplasms
2
Glioblastoma
2
Ganglioneuroblastoma
2
Familial ependymoma
2
Drug-Related Side Effects and Adverse Reactions
2
Choroid Plexus Neoplasms
2
Interventions
Cyclophosphamide
8
Temozolomide
6
Topotecan
5
Melphalan
5
Granulocyte Colony-Stimulating Factor
5
X-Rays
4
Phantoms, Imaging
4
Irinotecan
4
palbociclib
3
fludarabine
3
Vincristine
3
Specimen Handling
3
Sirolimus
3
Magnetic Resonance Spectroscopy
3
Busulfan
3
Bone Marrow Transplantation
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
ivosidenib
2
irinotecan sucrosofate
2
cabozantinib
2
abemaciclib
2
Zoledronic Acid
2
Vemurafenib
2
Nuclear Medicine Department, Hospital
2
Nivolumab
2
Mesna
2
LY3023414
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
etoposide phosphate
×
CNS
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled